Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients
NCT01870908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 664
Last updated 2015-10-05
Summary
This study is to evaluate the safety and the effectiveness of treatment with tacrolimus and biological agents.
Conditions
Interventions
- DRUG
- DRUG
-
biological agents
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)
NCT00256919 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
NCT02373813 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
NCT01172639 ·Status: COMPLETED ·Phase: PHASE4
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
NCT04485325 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment
NCT03112213 ·Status: COMPLETED
-
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)
NCT00520572 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00565409 ·Status: COMPLETED ·Phase: PHASE4
-
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
NCT00713544 ·Status: COMPLETED ·Phase: PHASE2
-
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT01230177 ·Status: COMPLETED
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
NCT00414661 ·Status: COMPLETED
-
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00503503 ·Status: COMPLETED
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
Niclosamide With Etanercept in Rheumatoid Arthritis
NCT03160001 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
NCT01577563 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
NCT00503139 ·Status: COMPLETED
-
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
NCT02874092 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
NCT01901185 ·Status: COMPLETED ·Phase: PHASE3